X4 Pharmaceuticals (XFOR) Earnings
|
Expand Research on XFOR
| Next EPS Date | 10/29/26 | EPS Growth Rate | +72.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +7.9% | Revenue Growth Rate | +28.4% |
| Average % Move 1-Wk after EPS | +2.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | -$0.19 | N/A | N/A | $2.26M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.13 | -$0.19 | +$0.06 | $8.81M | $2.28M | N/A |  | | Details | |
| 5/7/26 | Q126 | -$0.16 | $0.00 | -$0.16 | $2.71M | N/A | N/A | | | Details | |
| 3/17/26 | Q425 | -$0.22 | $0.00 | -$0.22 | $2.57M | N/A | N/A | | | Details | |
| 11/5/25 | Q325 | -$0.69 | $0.00 | -$0.69 | $1.76M | N/A | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$0.09 | N/A | N/A | $2.93M | N/A | N/A | N/A | ||
| 5/1/25 | Q125 | $0.04 | -$0.12 | +$0.16 | $28.81M | $12.03M | N/A | | | Details | |
| 3/25/25 | Q424 | -$0.20 | -$0.16 | -$0.04 | $1.43M | $990.71K | N/A | | | Details |
